These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 37774369)
1. Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation. Ivy ZK; Belcher JD; Khasabova IA; Chen C; Juliette JP; Abdulla F; Ruan C; Allen K; Nguyen J; Rogness VM; Beckman JD; Khasabov SG; Gupta K; Taylor RP; Simone DA; Vercellotti GM Blood; 2023 Nov; 142(22):1918-1927. PubMed ID: 37774369 [TBL] [Abstract][Full Text] [Related]
2. Critical role of C5a in sickle cell disease. Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594 [TBL] [Abstract][Full Text] [Related]
3. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease. Belcher JD; Nguyen J; Chen C; Abdulla F; Conglin R; Ivy ZK; Cummings J; Dudler T; Vercellotti GM Transl Res; 2022 Nov; 249():1-12. PubMed ID: 35878790 [TBL] [Abstract][Full Text] [Related]
4. Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis. Uhelski ML; Gupta K; Simone DA Pain; 2017 Sep; 158(9):1711-1722. PubMed ID: 28570479 [TBL] [Abstract][Full Text] [Related]
5. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice. Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118 [TBL] [Abstract][Full Text] [Related]
6. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079 [TBL] [Abstract][Full Text] [Related]
7. Sensitization of nociceptors by prostaglandin E Khasabova IA; Uhelski M; Khasabov SG; Gupta K; Seybold VS; Simone DA Blood; 2019 May; 133(18):1989-1998. PubMed ID: 30796025 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of DAGLβ as a therapeutic target for pain in sickle cell disease. Khasabova IA; Gable J; Johns M; Khasabov SG; Kalyuzhny AE; Golovko MY; Golovko SA; Kiven S; Gupta K; Seybold VS; Simone DA Haematologica; 2023 Mar; 108(3):859-869. PubMed ID: 35615929 [TBL] [Abstract][Full Text] [Related]
9. Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness. Cain DM; Vang D; Simone DA; Hebbel RP; Gupta K Br J Haematol; 2012 Feb; 156(4):535-44. PubMed ID: 22171826 [TBL] [Abstract][Full Text] [Related]
13. Plasma Concentration of 12-Hydroxyeicosatetraenoic Acid, Single Nucleotide Polymorphisms of 12-Lipooxygenase Gene and Vaso-Occlusion in Sickle Cell Disease. Duru AN; Ocheni S; Ibegbulam O; Okpala I Front Genome Ed; 2021; 3():722190. PubMed ID: 34713264 [No Abstract] [Full Text] [Related]
14. Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia. Belcher JD; Gomperts E; Nguyen J; Chen C; Abdulla F; Kiser ZM; Gallo D; Levy H; Otterbein LE; Vercellotti GM PLoS One; 2018; 13(10):e0205194. PubMed ID: 30308028 [TBL] [Abstract][Full Text] [Related]
15. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate. Belcher JD; Chen C; Nguyen J; Zhang P; Abdulla F; Nguyen P; Killeen T; Xu P; O'Sullivan G; Nath KA; Vercellotti GM Antioxid Redox Signal; 2017 May; 26(14):748-762. PubMed ID: 26914345 [TBL] [Abstract][Full Text] [Related]
16. Functional MRI BOLD response in sickle mice with hyperalgesia. Wang Y; Wang X; Chen W; Gupta K; Zhu XH Blood Cells Mol Dis; 2017 Jun; 65():81-85. PubMed ID: 28579187 [TBL] [Abstract][Full Text] [Related]
17. Significant Quantitative Differences in Orexin Neuronal Activation After Pain Assessments in an Animal Model of Sickle Cell Disease. Richardson K; Sweatt N; Tran H; Apprey V; Uthayathas S; Taylor R; Gupta K Front Mol Biosci; 2020; 7():5. PubMed ID: 32118032 [TBL] [Abstract][Full Text] [Related]
18. Endothelial VWF is critical for the pathogenesis of vaso-occlusive episode in a mouse model of sickle cell disease. Shi H; Shao B; Gao L; Venkatesan T; McDaniel JM; Zhou M; McGee S; Yu P; Ahamed J; Journeycake J; George JN; Xia L Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2207592119. PubMed ID: 35969769 [TBL] [Abstract][Full Text] [Related]
19. Children and adolescents with sickle cell disease have worse cold and mechanical hypersensitivity during acute painful events. Brandow AM; Hansen K; Nugent M; Pan A; Panepinto JA; Stucky CL Pain; 2019 Feb; 160(2):407-416. PubMed ID: 30247266 [TBL] [Abstract][Full Text] [Related]
20. Exacerbated metabolic changes in skeletal muscle of sickle cell mice submitted to an acute ischemia-reperfusion paradigm. Chatel B; Messonnier LA; Vilmen C; Bernard M; Pialoux V; Bendahan D Clin Sci (Lond); 2018 Oct; 132(19):2103-2115. PubMed ID: 30185507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]